Yu-Quan Wei

发表

Free energy profiles for monomer capture in Grubbs‐ and SHOP‐type olefin polymerization catalysts: A constraint ab initio molecular dynamics study

Bing Shi, Sheng-Yong Yang, Ming-Li Xiang, 2007, J. Comput. Chem..

An integrated scheme for feature selection and parameter setting in the support vector machine modeling and its application to the prediction of pharmacokinetic properties of drugs

Hui Zhang, Chang-Ying Ma, Lin-Li Li, 2009, Artif. Intell. Medicine.

Therapeutic target database update 2014: a resource for targeted therapeutics

Feng Xu, Cheng Zhang, Sheng-Yong Yang, 2013, Nucleic Acids Res..

Discovery of Novel Pim-1 Kinase Inhibitors by a Hierarchical Multistage Virtual Screening Approach Based on SVM Model, Pharmacophore, and Molecular Docking

Xin Chen, Lin-Li Li, Sheng-Yong Yang, 2011, J. Chem. Inf. Model..

Three-class classification models of logS and logP derived by using GA–CG–SVM approach

Wei Li, Hui Zhang, Chang-Ying Ma, 2009, Molecular Diversity.

Detailed conformational dynamics of juxtamembrane region and activation loop in c‐Kit kinase activation process

Ming-Li Xiang, Yu-Quan Wei, Yuquan Wei, 2008, Proteins.

Towards more accurate pharmacophore modeling: Multicomplex-based comprehensive pharmacophore map and most-frequent-feature pharmacophore model of CDK2.

Yu-Quan Wei, Ji-Xia Ren, Huan-Zhang Xie, 2008, Journal of molecular graphics & modelling.

Comparative Proteomics and Correlated Signaling Network of Rat Hippocampus in the Pilocarpine Model of Temporal Lobe Epilepsy

Ying Zhang, Yu-Quan Wei, Shu-Fang Liang, 2007 .

Targeting Pin1 by inhibitor API‐1 regulates microRNA biogenesis and suppresses hepatocellular carcinoma development

Yong Peng, Wenchen Pu, Yu-Quan Wei, 2018, Hepatology.

Systems Biology Modeling Reveals a Possible Mechanism of the Tumor Cell Death upon Oncogene Inactivation in EGFR Addicted Cancers

Yu-Quan Wei, Shi-Dong Luo, Sheng-Yong Yang, 2011, PloS one.

Pharmacophore modeling and virtual screening studies of checkpoint kinase 1 inhibitors.

Yu-Quan Wei, Sheng-Yong Yang, Lin-Li Li, 2009, Chemical & pharmaceutical bulletin.

Structural optimization and structure-activity relationships of N2-(4-(4-Methylpiperazin-1-yl)phenyl)-N8-phenyl-9H-purine-2,8-diamine derivatives, a new class of reversible kinase inhibitors targeting both EGFR-activating and resistance mutations.

Yu-Quan Wei, Yong Xu, Ren-Lin Zheng, 2012, Journal of medicinal chemistry.

Genetic Vaccines and Therapy

Yu-Quan Wei, Yang Wu, N. Tordo, 2009 .

Pin1 impairs microRNA biogenesis by mediating conformation change of XPO5 in hepatocellular carcinoma

Yong Peng, Wenchen Pu, Yu-Quan Wei, 2018, Cell Death & Differentiation.

Pharmacophore modeling study based on known spleen tyrosine kinase inhibitors together with virtual screening for identifying novel inhibitors.

Yu-Quan Wei, Ji-Xia Ren, Huan-Zhang Xie, 2009, Bioorganic & medicinal chemistry letters.

Integrated computational model of cell cycle and checkpoint reveals different essential roles of Aurora-A and Plk1 in mitotic entry.

Yu-Quan Wei, Shi-Dong Luo, Sheng-Yong Yang, 2011, Molecular bioSystems.

Taking Quinazoline as a General Support‐Nog to Design Potent and Selective Kinase Inhibitors: Application to FMS‐like Tyrosine Kinase 3

Li Yang, Yu-Quan Wei, Xiao-Yu Qing, 2010, ChemMedChem.

Antitumor and antimetastatic activities of chloroquine diphosphate in a murine model of breast cancer.

Wei Shi, Yu-Quan Wei, Ying-Lan Zhao, 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

In Vivo Ovarian Cancer Gene Therapy Using CRISPR-Cas9.

Ping Wang, Xia Zhao, Wei Du, 2018, Human gene therapy.

Pharmacophore Modelling and Virtual Screening for Identification of New Aurora‐A Kinase Inhibitors

Ming-Li Xiang, Yu-Quan Wei, Ying-Lan Zhao, 2008, Chemical biology & drug design.

Challenges in CRISPR/CAS9 Delivery: Potential Roles of Nonviral Vectors.

Yu-Quan Wei, Ling Li, Zhi-Yao He, 2015, Human gene therapy.